Evidence map›Paper›PMID 39803353›Full record

ArticleMalariaWorld journal2025

Prevalence and genetic diversity of polymorphisms in

Oléfongo Dagnogo, Ako A B Ako, Dougba N Dago, Kouamé B A Kouman, N'golo D Coulibaly, Kouakou B Bla, Offianan A Touré, Allico J Djaman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MalariaWorld journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oléfongo DagnogoBiosciences Training and Research Unit (UFR), Felix Houphouët-Boigny University, Abidjan, Côte d'Ivoire.
Ako A B AkoDepartment of Parasitology-Mycology, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Dougba N DagoTraining and Research Unit (UFR) of Biological Sciences, Peleforo Gon Coulibaly University, Korhogo, Côte d'Ivoire.
Kouamé B A KoumanDepartment of Parasitology-Mycology, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
N'golo D CoulibalyDepartment of Parasitology-Mycology, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Kouakou B BlaBiosciences Training and Research Unit (UFR), Felix Houphouët-Boigny University, Abidjan, Côte d'Ivoire.
Offianan A TouréDepartment of Parasitology-Mycology, Pasteur Institute of Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Allico J DjamanBiosciences Training and Research Unit (UFR), Felix Houphouët-Boigny University, Abidjan, Côte d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methodology: Blood samples were collected in Anonkoua-kouté, Port-Bouët, and Ayamé from 94 patients with microscopically confirmed uncomplicated Results: For all three study sites, 93 (93/94, i.e. 98.94%), 86 (86/94, i.e. 94.49%) and 74 (74/94, i.e. 78.72%) DNA fragments from patient isolates were successfully amplified for the Conclusions: More than a decade after the abandonment of the use of CQ and the adoption of sulfadoxinepyrimethamine (SP) as intermittent preventive treatment (IPT) for pregnant women, the prevalence of alleles associated with CQ chemoresistance, represented by the K76T mutation in the

Identifiers

PMID39803353
PMCPMC11716317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.